Afficher la notice abrégée

dc.contributor.authorFlook, Marisa
dc.contributor.authorEscalera Balsera, Alba
dc.contributor.authorRybakowska, Paulina
dc.contributor.authorFrejo, Lidia
dc.contributor.authorBatuecas Caletrio, Ángel 
dc.contributor.authorAmor Dorado, Juan C.
dc.contributor.authorSoto Varela, Andrés
dc.contributor.authorAlarcón Riquelme, Marta
dc.contributor.authorLópez Escámez, José Antonio
dc.date.accessioned2025-02-06T10:18:09Z
dc.date.available2025-02-06T10:18:09Z
dc.date.issued2023
dc.identifier.citationFlook, M., Escalera-Balsera, A., Rybakowska, P., Frejo, L., Batuecas-Caletrio, A., Amor-Dorado, J. C., Soto-Varela, A., Alarcón-Riquelme, M., & Lopez-Escamez, J. A. (2023). Single-cell immune profiling of Meniere Disease patients. Clinical Immunology, 252. https://doi.org/10.1016/J.CLIM.2023.109632es_ES
dc.identifier.issn1521-6616
dc.identifier.urihttp://hdl.handle.net/10366/163542
dc.description.abstract[EN]Background: Meniere Disease (MD) is an inner ear syndrome, characterized by episodes of vertigo, tinnitus and fluctuating sensorineural hearing loss. The pathological mechanism leading to sporadic MD is still poorly un derstood, however an allergic inflammatory response seems to be involved in some patients with MD. Objective: Decipher an immune signature associated with the syndrome. Methods: We performed mass cytometry immune profiling on peripheral blood from MD patients and controls. We analyzed differences in state and differences in abundance of the different cellular subsets. IgE levels were quantified through ELISA on supernatant of cultured whole blood. Results: We have identified two clusters of individuals according to the single cell cytokine profile. These clusters presented differences in IgE levels, immune cell population abundance, including a reduction of CD56dim NKcells, and changes in cytokine expression with a different response to bacterial and fungal antigens. Conclusion: Our results support a systemic inflammatory response in some MD patients that show a type 2 response with allergic phenotype, which could benefit from personalized IL-4 blockers.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.subjectAllergyes_ES
dc.subjectInflammationes_ES
dc.subjectCytokineses_ES
dc.subjectMass cytometryes_ES
dc.subjectMeniere Diseasees_ES
dc.subject.meshMeniere Disease *
dc.subject.meshCytokines *
dc.subject.meshInflammation *
dc.titleSingle-cell immune profiling of meniere disease patientses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://www.sciencedirect.com/science/article/pii/S1521661623001316?via%3Dihubes_ES
dc.identifier.doi10.1016/j.clim.2023.109632
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.journal.titleClinical Immunologyes_ES
dc.volume.number252es_ES
dc.page.initial109632es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsinflamación *
dc.subject.decsenfermedad de Meniere *
dc.subject.decscitocinas *


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée